- Home
- WINA vs SANA Comparison
WINA vs SANA Comparison
Compare WINA & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WINA | SANA |
|---|---|---|
| Founded | 1988 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 2006 | 2021 |
Fundamental Metrics
Financial Performance| Metric | WINA | SANA |
|---|---|---|
| Price | $370.76 | $3.01 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $7.80 |
| AVG Volume (30 Days) | 33.9K | ★ 3.7M |
| Earning Date | 04-15-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.76% | N/A |
| EPS Growth | 3.76 | ★ 17.24 |
| EPS | ★ 2.50 | N/A |
| Revenue | ★ $86,055,700.00 | N/A |
| Revenue This Year | $5.55 | N/A |
| Revenue Next Year | $6.03 | N/A |
| P/E Ratio | $145.37 | ★ N/A |
| Revenue Growth | ★ 5.86 | N/A |
| 52 Week Low | $338.18 | $1.99 |
| 52 Week High | $526.81 | $6.55 |
Technical Indicators
Market Signals| Indicator | WINA | SANA |
|---|---|---|
| Relative Strength Index (RSI) | 47.71 | 38.54 |
| Support Level | $358.01 | $2.72 |
| Resistance Level | $483.43 | $3.43 |
| Average True Range (ATR) | 12.92 | 0.20 |
| MACD | 2.71 | -0.03 |
| Stochastic Oscillator | 84.14 | 10.71 |
Price Performance
Historical ComparisonAbout WINA Winmark Corporation
Winmark Corp is a franchisor of value-oriented retail store concepts that buy, sell, and trade gently used merchandise. The company has one reportable segment, including Franchising, and one non-reportable segment, Leasing. The franchising segment franchises value-oriented retail stores that buy, sell, trade, and consign merchandise as well as provide strategic consulting services relating to franchising. The leasing segment includes the middle-market equipment leasing business and small-ticket financing business. It generates a majority of its revenue from the Franchising segment.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.